In conclusion, our immunohistochemical results indicate that CD133 expression in pancreatic head cancer is associated with histological type, lymphatic invasion, lymph node metastasis, VEGF-C expression, and prognosis. This evidence concerns the gene VEGFC and metastatic malignant neoplasm in the lymph nodes.